To find the most relevant journal, please insert appropriate keyword to facilitate search.
Search Results: CSCI
Current Cell Science
ISSN: 2772-6215 (Print)
eISSN: 2772-6223 (Online)
Aims and Scope:Current Cell Science is an international peer-reviewed journal in the field of cell sciences for the benefit of the biological community. Current Cell Science is committed to publishing the full range of topics in cell sciences. The single most important criterion for acceptance is scientific excellence.
Current Cell Science aims to cover all the latest and outstanding developments in integrative cell science. Each issue of the journal includes timely in-depth/mini reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of cell biology, molecular biology, biochemistry, genetics, physiology and clinical aspects. Invited and unsolicited review articles are welcome. Articles will include those that pose and test a significant hypothesis that will provide novel perspectives and approaches to understanding cell sciences, and will stimulate the interest of the broad readership of the journal. The journal encourages contributions describing researches related to cell metabolism, cell communication, cell signaling, cell cycle, proliferation, apoptosis, and cell composition, including research in biomedical fields such as cancer, and other diseases. Research in cell sciences is also interconnected to other fields such as genetics, molecular genetics, physiology, cellular biochemistry, molecular biology, medical microbiology, immunology, and cytochemistry.
Current Cell Science is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
Current Cell Science aims to cover all the latest and outstanding developments in integrative cell science. Each issue of the journal includes timely in-depth/mini reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of cell biology, molecular biology, biochemistry, genetics, physiology and clinical aspects. Invited and unsolicited review articles are welcome. Articles will include those that pose and test a significant hypothesis that will provide novel perspectives and approaches to understanding cell sciences, and will stimulate the interest of the broad readership of the journal. The journal encourages contributions describing researches related to cell metabolism, cell communication, cell signaling, cell cycle, proliferation, apoptosis, and cell composition, including research in biomedical fields such as cancer, and other diseases. Research in cell sciences is also interconnected to other fields such as genetics, molecular genetics, physiology, cellular biochemistry, molecular biology, medical microbiology, immunology, and cytochemistry.
- Analytical biotechnology (biosensing, advanced technology for detection of bioanalysis)
- Applied microbiology
- Bioinformatics (computational biopharmaceutics and modeling) in cells
- Biosafety
- Biotech ethics
- Cancer cells and translational oncology (cancer biology, targeting, gene therapy, cancer therapy, cancer drug development)
- Cell omics (genomics, proteomics, metabolomics and systems biology)
- Cell, tissue and organoid
- Cells and environmental biotechnology
- DNA/protein engineering and processing
- Drug delivery and cell targeting
- Molecular pharmaceutics and molecular pharmacology in cells
- Nanobiotechnology in cells
- Regenerative medicine (stem cells, tissue engineering and biomaterials)
- Synthetic biotechnology
- Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)
- Translational immunology (cell therapies, antibody engineering, xenotransplantation)
Current Cell Science is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
Editor-in-Chief:
Masayoshi Yamaguchi,
Special Issues With Active Call for Papers
Submission closes on: Dec 31, 2025
Molecular Landscape of Pathology &Drug Design for Oncology
Human cancer is accompanied with genetic or molecular alteration. These kinds of human pathogenesis are commonly aggressive and resistant to conventional drugs (inhibitory to overall condition and signs). Finding the molecular targets of these diseases is very helpful for disease treatments and drug development. This special issue sets as a platform to discuss novel drug targets and mechanisms for cancers. see more